Navigation Links
Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus Meeting on the Primary Treatment of Early Breast Cancer
Date:6/26/2009

(ASCO) and the National Comprehensive Cancer Network (NCCN) guidelines, and extensively reimbursed in the United States. To date, physicians have used Oncotype DX for breast cancer treatment planning in more than 100,000 patients in over 40 countries worldwide.

"We are pleased that the prestigious St. Gallen International Consensus recognizes the benefit that validated genomic tests, such as Oncotype DX, can offer to patients diagnosed with early stage breast cancer," said Gary Palmer, Vice President of Medical Affairs, Genomic Health. "We believe these guidelines support the expansion of Oncotype DX in the European market and should help establish favorable reimbursement policies, making our test readily available for physicians and patients in this important region."

Aiming to provide evidence-based, scientifically valid recommendations for the treatment of early breast cancer in clinical practice, the St. Gallen consensus guidelines are determined bi-annually by a panel of more than 30 breast cancer experts from around the world. This is the first time that a European body of experts has supported the use of a validated multigene-profiling assay as an adjunct to high-quality phenotyping of breast cancer in cases where the indication for adjuvant chemotherapy is uncertain.

"These new guidelines provide further evidence that the international clinical community sees the value of advanced molecular diagnostics in helping make more informed, individualized breast cancer treatment decisions," said Dr. Joseph Gligorov, Tenon Hospital, Paris. "More patients for whom the prognostic evaluation is still uncertain with the classical and optimal pathological tools, should now be offered the opportunity to benefit from these new tests, as it provides both physicians and patients with valuable, accurate information about their individual cancer and greater confidence in treatment selection."

'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Lethality of H1N1 Influenza Virus Increasing According to Latest Analysis of Virus Peptide Genomic Data
2. Matrix Genomics, Elizabeth Corder, PhD - Gene Variation in the LRRK2 Gene and High Risk for Parkinson's Disease
3. Sirius Genomics Announces 2009 Board of Directors
4. Quest Diagnostics to Present Genomic Studies Related to New Testing Techniques for Leukemia and Prostate Cancer at 2009 ASCO Meeting
5. Agendia Opens CLIA-Registered U.S. Genomics Laboratory
6. Swine Flu (H1N1) Infectivity to Increase Markedly and Lethality to Remain Low According to Latest Replikin* Peptide Genomic Data
7. Transgenomic, Inc. Announces Appointment of New Board Members
8. AutoGenomics New RVP Assay Addresses Current Challenge to Detect Flu A - Swine H1N1
9. Transgenomic, Inc. Reports First Quarter 2009 Results
10. Reminder: Transgenomic Inc. Announces First Quarter 2009 Earnings Release Conference Call Webcast
11. Frost & Sullivan Awards Precision Biosciences for Technology Innovation and Molecular Design Process in the Genomics Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 2015 The laboratory information management systems ... a number of technological advancements due to factors such ... need to integrate healthcare systems, and increasing government support ... system integration. Key players in the market focus on ...
(Date:1/22/2015)... Dr. Greg Leyer of UAS Labs recently was ... Pre-Conference seminar on probiotics in San Diego, CA. , ... conference for health care professionals. This year’s pre-conference seminar was ... in health. Dr. Leyer spoke about the emerging topics and ...
(Date:1/22/2015)... Jan. 22, 2015   Cypher Genomics, Inc., ... (NASDAQ: SQNM ), the leading molecular ... next generation noninvasive prenatal tests (NIPT). Through this ... called Mantis™, to advance analysis of clinically-relevant fetal ...
(Date:12/24/2014)... Dec. 24, 2014  United Therapeutics Corporation (NASDAQ: ... MDT ) has submitted a pre-market approval application ... the use of Medtronic,s SynchroMed ® II implantable ... use with United Therapeutics, Remodulin ® (treprostinil) Injection ...
Breaking Biology Technology:Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 3Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 4Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4
... Focus on Pharma & Life Science, Gerresheimer AG ... business segment, which primarily manufactures system,components for suppliers to ... of pharma & life science. For this purpose the ... bids., "Through the sale of the technical plastics ...
... -, BRISBANE, Calif., July 31 InterMune, Inc.,(Nasdaq: ... and six months ended June 30, 2008. InterMune reported a ... or $0.68 per share,compared with a net loss of $19.8 ... Dan Welch, Chairman, Chief Executive Officer and President of ...
... ANGELES, July 31 Vista Partners announced today,that ... "Raptor,s drug,candidates, which target billion dollar markets, are ... Company will present Phase 2 results for,Convivia(TM) sometime ... expect FDA approval,of Delayed Release (DR) Cysteamine for ...
Cached Biology Technology:Gerresheimer Starts Process to Sell off its Business Segment of Technical Plastics 2InterMune Reports Second Quarter 2008 Financial Results and Business Highlights 2InterMune Reports Second Quarter 2008 Financial Results and Business Highlights 3InterMune Reports Second Quarter 2008 Financial Results and Business Highlights 4InterMune Reports Second Quarter 2008 Financial Results and Business Highlights 5InterMune Reports Second Quarter 2008 Financial Results and Business Highlights 6InterMune Reports Second Quarter 2008 Financial Results and Business Highlights 7InterMune Reports Second Quarter 2008 Financial Results and Business Highlights 8InterMune Reports Second Quarter 2008 Financial Results and Business Highlights 9InterMune Reports Second Quarter 2008 Financial Results and Business Highlights 10Vista Partners Updates Coverage on Raptor Pharmaceuticals Corp. (OTC Bulletin Board: RPTP) 2
(Date:12/19/2014)... Dec. 18, 2014  23andMe, Inc., the leading personal genetics company, ... differences in genetic ancestry of individuals from across ... arrived more than four hundred years ago, the ... for peoples from different continents. This study illuminates how American ...
(Date:12/17/2014)... 2014 The Defense Logistics Agency is insourcing its ... counterfeit microcircuits from entering into its supply chain. ... anti-counterfeit initiative dubbed DNA marking. The capability will validate ... throughout the supply chain. The new quality control measures ...
(Date:12/17/2014)... and Markets ( http://www.researchandmarkets.com/research/9zq33j/global_chemical ) has announced ... 2015-2019" report to their offering. ... upcoming in this market is the increasing demand for ... recording of patient data for quick and correct diagnosis ...
Breaking Biology News(10 mins):23andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2
... played out 73 million years ago in northwestern Alberta ... species in northwestern Alberta. University of Alberta student ... from Italy, made the discovery near Grande Prairie, 450 ... came across a nesting site and found the remains ...
... release is available in German . ... of the limited amount of fossil fuels available, renewable ... other plant waste, are becoming the focus of considerable ... conversion of biomass into bio-oil, a highly promising renewable ...
... 2009) The National Oceanic and Atmospheric Administration ... of a new cooperative institute which will be ... Florida Atlantic University in Fort Pierce, Florida, and ... (UNCW). This is the single largest competitive research ...
Cached Biology News:New dinosaur species possible in Northwestern Alberta 2Biomass as a source of raw materials 2NOAA awards $22.5 million to Harbor Branch/FAU and UNCW for new cooperative institute 2NOAA awards $22.5 million to Harbor Branch/FAU and UNCW for new cooperative institute 3
... new HydroFlex platform provides excellent performance, ... of 96-well format applications, including washing ... arrays, and vacuum filtration-to-waste, such as ... on-line control features set new standards ...
... Obtain Clean and Accurate Results Laser ... increase the sensitivity and accuracy of molecular ... cell types and multi-cellular structures isolated from ... approach to microdissection-developed in 1996 at the ...
... raised against a partial recombinant ... ZFHX4 (NP_078997, 2 a.a. ... protein with GST tag. ... NM_024721 Protein ...
... binding specificity and signaling of the members ... be modified by alternative splicing--which has important ... you can perform a classical expression profiling ... different alternatively spliced forms of the gene ...
Biology Products: